REQUEST A DEMO
Total
USD $0.00
Search more companies

Acies Pharmaceutical Private Limited (India)

Main Activities: Other Business Support Services
Full name: Acies Pharmaceutical Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Acies Pharmaceutical Private Limited is an unlisted company, incorporated on 19/04/2019. It has its registered office in the State of Uttarakhand, India. Company's corporate identification number (CIN) is U74999UR2019PTC009735 and registration number is 009735. The company is a trade company, it is engaged in wholesale trading.

Legal Address
First Floor 74/1 Nari Shilip Marg
Dehradun; Uttarakhand; Postal Code: 248001

Contact Details: Purchase the Acies Pharmaceutical Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Acies Pharmaceutical Private Limited report to view the information.
Registered Capital:
Purchase the Acies Pharmaceutical Private Limited report to view the information.
Incorporation Date:
April 19, 2019
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Acies Pharmaceutical Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
28.55%
Total operating revenue
29.38%
Operating profit (EBIT)
33.94%
EBITDA
33.27%
Net Profit (Loss) for the Period
33.94%
Total assets
36.29%
Total equity
90.89%
Operating Profit Margin (ROS)
0.3%
Net Profit Margin
0.3%
Return on Equity (ROE)
-25.01%
Debt to Equity Ratio
-12.41%
Quick Ratio
1.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?